Complejo Hospitalario Torrecárdenas (Almería, SPAIN)
- Address
- Avenida Torrecardenas, S/N, 04009, Almería, Almería, Spain
Complejo Hospitalario Torrecárdenas - Stroke & Neurovascular Research
Complejo Hospitalario Torrecárdenas in Almería, Spain, is actively engaged in advanced neurovascular research, with particular emphasis on acute cerebrovascular disease management and innovative therapeutic interventions. The center demonstrates expertise in evaluating cutting-edge treatment protocols for complex stroke presentations requiring specialized endovascular approaches.
- Acute ischemic stroke with tandem lesion management
- Endovascular treatment optimization and reocclusion prevention
- Antiplatelet therapy comparison studies in neurovascular interventions
The research program focuses on critical safety and efficacy outcomes in acute ischemic stroke patients, particularly those with tandem lesions requiring complex intervention strategies. By investigating pharmacological approaches such as tirofiban versus aspirin, the center contributes to evidence-based protocols aimed at reducing reocclusion rates and minimizing hemorrhagic transformation complications following endovascular procedures, ultimately working to improve neurological outcomes for stroke patients.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 567 other sites in Spain
Therapeutic Area Benchmark — Spain
Select a therapeutic area to compare against other sites in Spain.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Spain
Market Share
Country: Spain
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Complejo Hospitalario Torrecárdenas (Almería, SPAIN)
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Safety of Tirofiban Versus Intravenous Acetylsalicylic Acid in Endovascular Treatment of Acute Ischemic Stroke with Tandem Lesion | Fundacion Para La Gestion De La Investigacion En Salud De Sevilla | Phase III | Not Recruiting | May 2022 | Mar 2026 |
IMP list
lock Showing 1 of 4 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Acetylsalicylic Acid | 1 | Unknown | 2022-05-01 | 2022-05-01 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.